BioAge Labs

Filter

År

Typ

Språk

Rensa

2025-08-20 22:30:00 BioAge Labs to Present at Upcoming Investor Conferences 4,44 USD | +0,45%

2025-08-15 15:00:00 BioAge Labs Announces First Participant Dosed in Phase 1 Clinical Trial of BGE-102, a Novel Brain-Penetrant NLRP3 Inhibitor 4,55 USD | +2,02%

2025-08-06 22:30:00 BioAge Labs Reports Second Quarter 2025 Financial Results and Provides Business Updates 4,33 USD | -2,48%

2025-06-22 00:00:00 BioAge Labs to Present Preclinical Data on APJ Agonism for Diabetic Obesity and Heart Failure at the American Diabetes Association (ADA) 85th Scientific Sessions

2025-06-17 15:00:00 BioAge Labs Expands Drug Discovery Platform with Data from Leading European Biobank 4,35 USD | -0,68%

2025-06-03 15:00:00 BioAge Expands APJ Agonist Pipeline with Oral Small-Molecule and Long-Acting Biologic Candidates 3,99 USD | -1,48%

2025-05-29 15:00:00 BioAge Labs completes IND-enabling studies for BGE-102, a potent, orally available, brain-penetrant NLRP3 inhibitor, and advances candidate toward the clinic 3,98 USD | 0,00%

2025-05-27 22:30:00 BioAge Labs to Present at Upcoming Investor Conferences 3,95 USD | -2,71%

2025-05-06 22:30:00 BioAge Labs Reports First Quarter 2025 Financial Results and Provides Business Updates 3,95 USD | -4,82%

2025-03-20 21:30:00 BioAge Labs Reports Full Year 2024 Financial Results and Provides Business Updates from the Fourth Quarter of 2024 4,38 USD | -1,35%

2025-02-20 22:30:00 BioAge Labs to Participate in TD Cowen's 45th Annual Health Care Conference 4,40 USD | +2,33%

↑	Select newer press release
↓	Select older press release
←	Navigate backwards
→	Navigate forward
Enter	Navigate to line in focus
Tab	Focus next link
A or 1	Open First attachment
S or 2	Open Second attachment
D or 3	Open Third attachment
F or 4	Open Fourth attachment
I	Show company information
PgUp	Select newest press release
PgDown	Select oldest press release
L	Focus on filer bar
N	Increase preview window size
M	Decrease preview window size
Esc	Escape from mode

BioAge Labs

Språk

Typ

År

Språk

Typ

Ett mail har skickats till den givna adressen. För att logga in, klicka på "Login" i mailet för att verifiera ditt konto

Företag

Pressmeddelanden